NDAORALTABLET
Approved
Jul 2024
Lifecycle
Growth
Competitive Pressure
0/100
Mechanism of Action
(JAK) inhibitor. JAKs mediate the signaling of a number of cytokines and growth factors that are important for hematopoiesis and immune function. JAK signaling involves recruitment of STATs (signal transducers and activators of transcription) to cytokine receptors, activation and subsequent…
Loss of Exclusivity
LOE Date
Oct 10, 2044
226 months away
Patent Expiry
Oct 10, 2044
Exclusivity Expiry
Jul 25, 2029